These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 5641176)

  • 1. Alternate-day corticosteroid therapy.
    Stoughton RB
    N Engl J Med; 1968 Apr; 278(16):915-6. PubMed ID: 5641176
    [No Abstract]   [Full Text] [Related]  

  • 2. Single dose alternate day corticosteroid therapy in posterior uveitis.
    Millett FE; Giles CL
    Eye Ear Nose Throat Mon; 1969 Aug; 48(8):456-8. PubMed ID: 5797447
    [No Abstract]   [Full Text] [Related]  

  • 3. Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation.
    Pedrosa MC; Rohrer RM; Kaplan MM
    Clin Transplant; 1995 Aug; 9(4):322-5. PubMed ID: 7579741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
    Moxley RT; Ashwal S; Pandya S; Connolly A; Florence J; Mathews K; Baumbach L; McDonald C; Sussman M; Wade C; ;
    Neurology; 2005 Jan; 64(1):13-20. PubMed ID: 15642897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prednisone dose spacing on plasma lipids.
    Galla JH; Curtis JJ; Woodford SY; Rees ED; Somes GW; Luke RG
    J Lab Clin Med; 1980 Jun; 95(6):801-7. PubMed ID: 6991620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of refractory Evans syndrome with alternate-day cyclosporine and prednisone.
    Rackoff WR; Manno CS
    Am J Pediatr Hematol Oncol; 1994 May; 16(2):156-9. PubMed ID: 8166369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of alternate day steroids and daily steroids in renal transplant recipients.
    Davisson NA; Westervelt FB; Bolton WK
    Proc Clin Dial Transplant Forum; 1980; 10():150-4. PubMed ID: 7050977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of advanced plasma cell myeloma with weekly cyclophosphamide and alternate-day prednisone.
    Brandes LJ; Israels LG
    Cancer Treat Rep; 1982 Jun; 66(6):1413-5. PubMed ID: 6177412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membranoproliferative glomerulonephritis: improved survival with alternate day prednisone therapy.
    McEnery PT; McAdams AJ; West CD
    Clin Nephrol; 1980 Mar; 13(3):117-24. PubMed ID: 7379361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternate-day prednisone therapy in IgA nephropathy. Preliminary analysis of a prospective, randomized, controlled trial.
    Julian BA; Barker C
    Contrib Nephrol; 1993; 104():198-206. PubMed ID: 8325030
    [No Abstract]   [Full Text] [Related]  

  • 11. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.
    Woodle ES; First MR; Pirsch J; Shihab F; Gaber AO; Van Veldhuisen P;
    Ann Surg; 2008 Oct; 248(4):564-77. PubMed ID: 18936569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An alternate-day corticosteroid regimen for pemphigus vulgaris. A 13-year prospective study.
    Chaidemenos GCh; Mourellou O; Koussidou T; Tsatsou F
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1386-91. PubMed ID: 17958846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of crescentic Henoch-Schoenlein purpura nephritis to corticosteroid and azathioprine therapy.
    Bergstein J; Leiser J; Andreoli SP
    Clin Nephrol; 1998 Jan; 49(1):9-14. PubMed ID: 9491279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternate day steroids and blood pressure control after renal transplantation.
    McHugh MI; Tanboga H; Wilkinson R
    Proc Eur Dial Transplant Assoc; 1980; 17():496-501. PubMed ID: 7017696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients.
    Pascuzzi RM; Coslett HB; Johns TR
    Ann Neurol; 1984 Mar; 15(3):291-8. PubMed ID: 6721451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of two prednisone exposures on mood and declarative memory.
    Brown ES; Beard L; Frol AB; Rush AJ
    Neurobiol Learn Mem; 2006 Jul; 86(1):28-34. PubMed ID: 16458545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternate-day steroid therapy for patients with primary Sjögren's syndrome.
    Tabbara KF; Frayha RA
    Ann Ophthalmol; 1983 Apr; 15(4):358-61. PubMed ID: 6660708
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy: report from the Southwest Pediatric Nephrology Study Group.
    Hogg RJ; Lee J; Nardelli N; Julian BA; Cattran D; Waldo B; Wyatt R; Jennette JC; Sibley R; Hyland K; Fitzgibbons L; Hirschman G; Donadio JV; Holub BJ;
    Clin J Am Soc Nephrol; 2006 May; 1(3):467-74. PubMed ID: 17699247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticosteroid-induced clinical adverse events: frequency, risk factors and patient's opinion.
    Fardet L; Flahault A; Kettaneh A; Tiev KP; Généreau T; Tolédano C; Lebbé C; Cabane J
    Br J Dermatol; 2007 Jul; 157(1):142-8. PubMed ID: 17501951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose, alternate day corticosteroids for systemic onset juvenile rheumatoid arthritis.
    Kimura Y; Fieldston E; Devries-Vandervlugt B; Li S; Imundo L
    J Rheumatol; 2000 Aug; 27(8):2018-24. PubMed ID: 10955346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.